Streetbeat News

Products Services

DIS

FOX

PARA

WBD

XLC

'Oppenheimer' dominated the 2024 Academy Awards, winning seven Oscars, including Best Picture. 'Poor Things' won three awards, with Emma Stone receiving Best Actress. Paramount Global, Warner Bros Discovery, Fox Corp, and Walt Disney Co saw stock gains post-awards, while the Communication Services Select Sector SPDR Fund remained flat.

Portfolio Pulse from Neil Dennis

March 11, 2024 | 8:48 pm

DVA

The American Diabetes Association (ADA) and DaVita (NYSE:DVA) have expanded their multi-year collaboration to advance chronic disease prevention, focusing on diabetes and chronic kidney disease (CKD). This expansion, announced during National Kidney Month, includes a $1.5 million contribution from DaVita to the ADA's initiatives. The partnership aims to increase awareness, education, and support, especially in communities of color disproportionately affected by these conditions. Efforts include creating educational materials, a dietitian program, and sponsoring ADA's State of Diabetes events.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:44 pm

ACAD

Acadia Pharmaceuticals' stock is trading lower following the announcement that its Phase 3 ADVANCE-2 trial of pimavanserin for treating negative symptoms of schizophrenia failed to meet the primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:40 pm

AVO

Mission Produce anticipates a slight sequential increase in avocado pricing, projecting a 10-15% rise from the Q2 2023 average of $1.30 per pound.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:36 pm

JNJ

Johnson & Johnson has submitted a Supplemental Biologics License Application to the FDA for the approval of TREMFYA (Guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:35 pm

FTEK

Fuel Tech has secured $2.1M in air pollution control orders, including two from new European customers for SCR technology, and contracts from existing customers in the Caribbean and the US for FUEL CHEM equipment and SNCR system upgrades, respectively. Deliveries are scheduled between Q2 2024 and Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:26 pm

MBIO

Mustang Bio reported a FY23 EPS of $(6.00), an improvement from $(10.09) YoY, alongside a significant decrease in cash and cash equivalents from $76.7 million to $7.0 million. The company made a $30.4 million payment to terminate existing debt and sold assets to uBriGene for $6 million upfront with a potential additional $5 million contingent payment. Research and development expenses decreased to $40.5 million from $62.5 million in 2022. Mustang Bio's lead clinical candidate, MB-106, showed a 100% overall response rate in Phase 1/2 clinical trials for certain hematologic malignancies. The FDA granted Orphan Drug Designation to MB-106 for WM treatment. Additionally, Mustang announced the FDA's acceptance of an IND for a Phase 1 trial of MB-109 for recurrent GBM and high-grade astrocytoma.

Portfolio Pulse from Happy Mohamed

March 11, 2024 | 8:24 pm

ORCL

Oracle Corp (ORCL) reported its fiscal third-quarter results, revealing a 7% year-over-year revenue increase to $13.3 billion, slightly missing estimates. Earnings per share were $1.41, surpassing expectations. The company saw significant growth in its cloud infrastructure and applications segments, with cloud infrastructure revenues up 49%. Oracle's CEO highlighted strong demand for its Gen2 AI infrastructure, expecting hypergrowth to continue. A quarterly dividend of $0.40 per share was announced. Post-earnings, ORCL shares rose 6.58% in after-hours trading.

Portfolio Pulse from Adam Eckert

March 11, 2024 | 8:17 pm

CVGW

Calavo Growers anticipates a strong rebound in earnings for Q2 and FY24 due to better avocado margins, enhanced tomato performance, and the ramp-up of the California avocado season.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:13 pm

CVGW

Calavo Growers reported that its Q1 results were impacted by temporary market dynamics within the avocado business, especially for smaller sized fruit. However, the company noted improvements in conditions during February and March.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:12 pm